The PSA test may help diagnose very early prostate cancer, before any symptoms develop. But there are advantages and disadvantages of having treatment for early prostate cancer.
There is no right or wrong answer about whether or not to have the PSA test. But it may help to think about whether you have any risk factors for prostate cancer and about your own preferences.
- If the test result is normal, you may feel more reassured.
- If your PSA level is slightly high, you can continue to have it monitored, especially if you have an increased risk.
- It can help to find prostate cancer before you have any symptoms.
- If further tests show you have an early, faster-growing prostate cancer, treatment may cure it or help you live longer.
- If your PSA level is raised, you may feel anxious and worry about having more tests.
- It is possible to have a normal PSA level and still have prostate cancer.
- Although a raised PSA level does not always mean you have cancer, you may still need more tests, such as a biopsy, which can cause complications.
- If you are diagnosed with prostate cancer, you will need to make decisions about treatments, which can have difficult side effects.
- Treating prostate cancer may not help you to live for longer, and treatments with possible risks and side effects can affect your quality of life.
Questions to think about before having a PSA test
To help you make your decision, you could think about the following questions:
- What would you do if your PSA level is high?
- What would you do if further tests find that you have an early prostate cancer?
- What difference will it make for you to know about an early prostate cancer?
Before you decide whether to have the PSA test, you may want to talk to your GP about it. You can also call our cancer support specialists on 0808 808 00 00. They can discuss the options with you and send you more information.
Benign prostatic hyperplasia (also called benign prostatic hypertrophy, or BPH)
Benign prostatic hyperplasia (BPH) is when the prostate increases in size. It is part of the normal ageing process and is common over the age of 50.
If you decide to have the PSA test, your GP or nurse will take a blood sample and send it to a laboratory to be tested.
If you are having the PSA test, you will usually have a rectal examination as well. This is when the doctor or nurse inserts a lubricated, gloved finger into your back passage (rectum) to feel the prostate. It may be uncomfortable, but it is quick and should not be painful.
Although there is no screening programme, if you are aged over 50 you can ask your GP for the PSA test. Or you may be offered one as part of a general health check.
Before you have the test, your GP or nurse will talk through the benefits and disadvantages of having your PSA checked. If you are aged under 50 but at higher risk of prostate cancer, you can talk to your GP about having the PSA test.
If you are transgender
If you are a trans man you do not have a prostate and do not need a PSA test.
Trans women and non-binary people assigned male at birth still have a prostate gland, whether they have had genital gender-affirming surgery or not. This means they may still get prostate cancer, although there is not enough evidence to know how common this is.
If you are a trans woman or non-binary person assigned male at birth and would like to have the PSA test, talk to your GP.
You may worry about talking to your doctor or practice nurse about this, but they are used to talking about many different needs. If you find it difficult to start the conversation, you could try showing them this information. You should talk about any worrying symptoms or concerns with your GP or nurse.
Prostate cancer UK have detailed information about trans women and prostate cancer.
The LGBT Foundation can also give you confidential advice and support. You can also talk to one of our cancer support specialists.
Your doctor may talk about a normal PSA level. Unlike some other blood tests, there is not one normal PSA level for everyone. The PSA level naturally gets higher as you get older and varies depending on the size of your prostate. The size of the prostate is different for each individual and the prostate gets bigger with age.
Your doctor will tell you what they think the normal level of PSA should be for you. They generally use these levels:
- A PSA level of up to 3 nanograms per millilitre of blood (3ng/ml) if you are in your 50s.
- A PSA level of up to 4ng/ml if you are in your 60s.
- A PSA level of up to 5ng/ml if you are in your 70s.
- There are no PSA level limits if you are aged 80 and over.
Your GP will refer you to see a specialist if:
- the PSA level is higher than normal and your rectal examination is not normal
- the PSA level is normal but your rectal examination is not normal.
If your PSA level is higher than normal but your rectal examination is normal, your GP usually checks your PSA level again before referring you to a specialist.
You will usually be seen within 2 weeks of your GP making a referral.
Research has shown that 1 PSA test is not reliable on its own:
- 75 out of 100 people who have a raised PSA level (75%) will not have prostate cancer.
- 1 out of 7 people who have a normal PSA level (14%) will have cancer.
You will usually have more than one PSA test before you are offered a biopsy or an MRI scan of the prostate. If the level of PSA is high in several tests, or is increasing each time the test is taken, you will be offered further tests.
Below is a sample of the sources used in our PSA test information. If you would like more information about the sources we use, please contact us at email@example.com
Guidelines on Prostate Cancer. European Association of Urologists (2016). Available from: uroweb.org/guideline/prostate-cancer
National Institute for Health and Care Excellence (NICE) Prostate cancer overview. NICE Pathways. Available from: www.pathways.nice.org.uk/pathways/prostate-cancer (accessed online from March 2017 until November 2017).
Prostate cancer: diagnosis and treatment. NICE Clinical Guideline (January 2014). Available from: www.nice.org.uk/guidance/cg175
Prostate cancer risk management programme: overview. Public Health England. Available from: www.gov.uk/guidance/prostate-cancer-risk-management-programme-overview
Surveillance report 2016 – Prostate cancer: diagnosis and management (2014). NICE guideline CG175.
Suspected cancer: recognition and referral. NICE Clinical Guideline (2015). Available from: www.nice.org.uk/guidance/NG12.
This information has been written, revised and edited by Macmillan Cancer Support’s Cancer Information Development team. It has been reviewed by expert medical and health professionals and people living with cancer. It has been approved by Senior Medical Editors, Dr Jim Barber, Consultant Clinical Oncologist and Dr Lisa Pickering, Consultant Medical Oncologist.
Our cancer information has been awarded the PIF TICK. Created by the Patient Information Forum, this quality mark shows we meet PIF’s 10 criteria for trustworthy health information.
Content under review
The language we use
We want everyone affected by cancer to feel our information is written for them.
We try to make sure our information is as clear as possible. We use plain English, avoid jargon, explain any medical words, use illustrations to explain text, and make sure important points are highlighted clearly.
We use gender-inclusive language and talk to our readers as ‘you’ so that everyone feels included. Where clinically necessary we use the terms ‘men’ and ‘women’ or ‘male’ and ‘female’. For example, we do so when talking about parts of the body or mentioning statistics or research about who is affected. Our aims are for our information to be as clear and relevant as possible for everyone.
You can read more about how we produce our information here.